Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-108391
Filing Date
2016-06-15
Accepted
2016-06-15 17:14:12
Documents
1
Period of Report
2016-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v442332_4.html 4  
1 OWNERSHIP DOCUMENT v442332_4.xml 4 3949
  Complete submission text file 0001144204-16-108391.txt   5515
Mailing Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121
Business Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121 908-864-4444
Sevion Therapeutics, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 4400 BISCAYNE BOULEVARD, 15TH FLOOR MIAMI FL 33137
Business Address
Rubin Steven D (Reporting) CIK: 0001381874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 161715980